AGENDA
Saturday, October 8, 2022
*agenda is subject to change
8:30 - 9:00 AM
Breakfast and Registration
9:00 - 9:05 AM
Welcome from Course Director
9:05 – 9:35 AM
Healthcare Policy in GI
John McManus (President of The McManus Group, LLC.)
Tracy Spicer (Partner, Avenue Solutions)
9:35 – 9:50 AM
Q&A / Panel Discussion
9:50 – 10:10 AM
Refractory IBS
Baharak Moshiree, MD (Atrium Health)
10:10 – 10:30 AM
When the Abdominal Bloating/Pain is More than IBS: CSID, Porphyria, and other IBS Imposters
Brooks D. Cash, MD (UT Health Science Center | Memorial Hermann Texas Medical Center)
10:30 – 10:40 AM
Q&A / Panel Discussion
10:40 – 10:50 AM
Break / Exhibits
10:50 – 11:10 AM
NASH: Current Management/Use of NITs
Mazen Noureddin, MD (Cedars Sinai)
11:10 –11:30 AM
NAFLD/NASH: Treatments on the Horizon
Stephen Harrison, MD (Summit Clinical Research)
11:30 – 11:50 AM
Hep B & Hep D: 2022 Update
Ira Jacobson, MD (NYU Langone Health)
11:50 – 12:00 PM
Q&A / Panel Discussion
12:00 – 12:30 PM
Break / Exhibits
12:30 – 1:15 PM
Lunch Industry-Sponsored Product Theater
1:15 - 1:45 PM
Break / Exhibits
1:45 – 2:05 PM
GI Genetic Syndromes as Pathway for Personalized Therapy
Axel Grothey, MD (West Cancer Center & Research Institute)
2:05 – 2:25 PM
Novel Technologies
Vasundhara Appalaneni, MD (Dayton Gastroenterology, Inc.)
2:25 – 2:45 PM
Cholestatic Liver Diseases: Best Practices &
Emerging Therapies
Ziad H. Younes, MD (One GI)
2:45 – 2:55 PM
Q&A / Panel Discussion
2:55 – 3:15 PM
What’s New in GI Pathology
Mary Peyton Gupta, MD (Gastro One Anatomic Pathology Laboratory)
3:15 – 3:35 PM
Treat to Target and Emerging Therapies in IBD Jason Ken Hou, MD, MS (Baylor College of Medicine)
3:35 – 4:05 PM
IBD Biologics and Crohn's Disease
David Schwartz, MD (Vanderbilt University Medical Center)
4:05 – 4:15 PM
Q&A / Panel Discussion
4:15 – 4:20 PM
Closing Remarks
4:20 – 4:50 PM
Break / Exhibits
4:50 – 5:35 PM
Industry-Sponsored Product Theater
5:35 – 7:35 PM
Conference Reception